Endoscopic Retrograde Cholangiopancreatography in the Diagnosis and Management of Cholangiocarcinoma

Clinics in Liver Disease

Volumn 14, Issue 2, 2010, Pages 333-348

  Coelho Prabhu, Nayantara ^a   Baron, Todd H ^a  

^a MAYO CLINIC ROCHESTER   (United States)

Author keywords

Cholangiocarcinoma; Diagnosis; Endoscopic retrograde cholangiopancreatography; Management

Indexed keywords

PHOTOSENSITIZING AGENT;

BARE METAL STENT; BILE DUCT CARCINOMA; BILIARY TRACT ENDOSCOPY; BRACHYTHERAPY; CANCER SURGERY; COMPUTER ASSISTED TOMOGRAPHY; COST EFFECTIVENESS ANALYSIS; DIAGNOSTIC ACCURACY; DIGITAL IMAGING; ENDOSCOPIC ECHOGRAPHY; ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY; FLUORESCENCE IN SITU HYBRIDIZATION; HUMAN; MAGNETIC RESONANCE CHOLANGIOPANCREATOGRAPHY; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PHOTODYNAMIC THERAPY; PROGNOSIS; RADIATION DOSE; REVIEW; SENSITIVITY AND SPECIFICITY;

ANIMALS; BILE DUCT NEOPLASMS; BILE DUCTS, INTRAHEPATIC; BRACHYTHERAPY; CHOLANGIOCARCINOMA; CHOLANGIOPANCREATOGRAPHY, ENDOSCOPIC RETROGRADE; DRAINAGE; HUMANS; PALLIATIVE CARE; PHOTOCHEMOTHERAPY; STENTS; TUMOR MARKERS, BIOLOGICAL;

EID: 77953000220     PISSN: 10893261     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cld.2010.03.011     Document Type: Review

References (107)

1. Nakeeb A., Pitt H.A., Sohn T.A., et al. Cholangiocarcinoma. A spectrum of intrahepatic, perihilar, and distal tumors. Ann Surg 224 (1996) 463
2. Malhi H., and Gores G.J. Cholangiocarcinoma: modern advances in understanding a deadly old disease. J Hepatol 45 (2006) 856
3. Lazaridis K.N., and Gores G.J. Cholangiocarcinoma. Gastroenterology 128 (2005) 1655
4. Chapman R.W. Risk factors for biliary tract carcinogenesis. Ann Oncol 10 Suppl 4 (1999) 308
5. Sharma M.P., and Ahuja V. Aetiological spectrum of obstructive jaundice and diagnostic ability of ultrasonography: a clinician's perspective. Trop Gastroenterol 20 (1999) 167
6. Manfredi R., Barbaro B., Masselli G., et al. Magnetic resonance imaging of cholangiocarcinoma. Semin Liver Dis 24 (2004) 155
7. Manfredi R., Masselli G., Maresca G., et al. MR imaging and MRCP of hilar cholangiocarcinoma. Abdom Imaging 28 (2003) 319
8. Gleeson F.C., Rajan E., Levy M.J., et al. EUS-guided FNA of regional lymph nodes in patients with unresectable hilar cholangiocarcinoma. Gastrointest Endosc 67 (2008) 438
9. Eloubeidi M.A., Chen V.K., Jhala N.C., et al. Endoscopic ultrasound-guided fine needle aspiration biopsy of suspected cholangiocarcinoma. Clin Gastroenterol Hepatol 2 (2004) 209
10. Fritscher-Ravens A., Broering D.C., Knoefel W.T., et al. EUS-guided fine-needle aspiration of suspected hilar cholangiocarcinoma in potentially operable patients with negative brush cytology. Am J Gastroenterol 99 (2004) 45
11. Rosch T., Hofrichter K., Frimberger E., et al. ERCP or EUS for tissue diagnosis of biliary strictures? A prospective comparative study. Gastrointest Endosc 60 (2004) 390
12. Park M.S., Kim T.K., Kim K.W., et al. Differentiation of extrahepatic bile duct cholangiocarcinoma from benign stricture: findings at MRCP versus ERCP. Radiology 233 (2004) 234
13. Glasbrenner B., Ardan M., Boeck W., et al. Prospective evaluation of brush cytology of biliary strictures during endoscopic retrograde cholangiopancreatography. Endoscopy 31 (1999) 712
14. Jailwala J., Fogel E.L., Sherman S., et al. Triple-tissue sampling at ERCP in malignant biliary obstruction. Gastrointest Endosc 51 (2000) 383
15. Macken E., Drijkoningen M., Van Aken E., et al. Brush cytology of ductal strictures during ERCP. Acta Gastroenterol Belg 63 (2000) 254
16. Mansfield J.C., Griffin S.M., Wadehra V., et al. A prospective evaluation of cytology from biliary strictures. Gut 40 (1997) 671
17. Pugliese V., Conio M., Nicolo G., et al. Endoscopic retrograde forceps biopsy and brush cytology of biliary strictures: a prospective study. Gastrointest Endosc 42 (1995) 520
18. Foutch P.G., Kerr D.M., Harlan J.R., et al. A prospective, controlled analysis of endoscopic cytotechniques for diagnosis of malignant biliary strictures. Am J Gastroenterol 86 (1991) 577
19. de Bellis M., Fogel E.L., Sherman S., et al. Influence of stricture dilation and repeat brushing on the cancer detection rate of brush cytology in the evaluation of malignant biliary obstruction. Gastrointest Endosc 58 (2003) 176
20. Fogel E.L., deBellis M., McHenry L., et al. Effectiveness of a new long cytology brush in the evaluation of malignant biliary obstruction: a prospective study. Gastrointest Endosc 63 (2006) 71
21. Ponchon T., Gagnon P., Berger F., et al. Value of endobiliary brush cytology and biopsies for the diagnosis of malignant bile duct stenosis: results of a prospective study. Gastrointest Endosc 42 (1995) 565
22. Dumonceau J.M., Macias Gomez C., Casco C., et al. Grasp or brush for biliary sampling at endoscopic retrograde cholangiography? A blinded randomized controlled trial. Am J Gastroenterol 103 (2008) 333
23. Schoefl R., Haefner M., Wrba F., et al. Forceps biopsy and brush cytology during endoscopic retrograde cholangiopancreatography for the diagnosis of biliary stenoses. Scand J Gastroenterol 32 (1997) 363
24. Sugiyama M., Atomi Y., Wada N., et al. Endoscopic transpapillary bile duct biopsy without sphincterotomy for diagnosing biliary strictures: a prospective comparative study with bile and brush cytology. Am J Gastroenterol 91 (1996) 465
25. de Bellis M., Sherman S., Fogel E.L., et al. Tissue sampling at ERCP in suspected malignant biliary strictures (Part 2). Gastrointest Endosc 56 (2002) 720
26. Khan S.A., Davidson B.R., Goldin R., et al. Guidelines for the diagnosis and treatment of cholangiocarcinoma: consensus document. Gut 51 Suppl 6 (2002) VI1
27. Weber A., von Weyhern C., Fend F., et al. Endoscopic transpapillary brush cytology and forceps biopsy in patients with hilar cholangiocarcinoma. World J Gastroenterol 14 (2008) 1097
28. Howell D.A., Parsons W.G., Jones M.A., et al. Complete tissue sampling of biliary strictures at ERCP using a new device. Gastrointest Endosc 43 (1996) 498
29. Bergquist A., Tribukait B., Glaumann H., et al. Can DNA cytometry be used for evaluation of malignancy and premalignancy in bile duct strictures in primary sclerosing cholangitis?. J Hepatol 33 (2000) 873
30. Sebo T.J. Digital image analysis. Mayo Clin Proc 70 (1995) 81
31. Baron T.H., Harewood G.C., Rumalla A., et al. A prospective comparison of digital image analysis and routine cytology for the identification of malignancy in biliary tract strictures. Clin Gastroenterol Hepatol 2 (2004) 214
32. Moreno-Luna L.E., Kipp B., Halling K.C., et al. Advanced cytologic techniques for the detection of malignant pancreatobiliary strictures. Gastroenterology 131 (2006) 1064
33. Levy M.J., Baron T.H., Clayton A.C., et al. Prospective evaluation of advanced molecular markers and imaging techniques in patients with indeterminate bile duct strictures. Am J Gastroenterol 103 (2008) 1263
34. Fritcher EG, Kipp BR, Halling KC, et al: A multivariable model using advanced cytologic methods for the evaluation of indeterminate pancreatobiliary strictures. Gastroenterology 136:2180, 2009.
35. Kipp B.R., Stadheim L.M., Halling S.A., et al. A comparison of routine cytology and fluorescence in situ hybridization for the detection of malignant bile duct strictures. Am J Gastroenterol 99 (2004) 1675
36. Tamada K., Nagai H., Yasuda Y., et al. Transpapillary intraductal US prior to biliary drainage in the assessment of longitudinal spread of extrahepatic bile duct carcinoma. Gastrointest Endosc 53 (2001) 300
37. Tamada K., Ido K., Ueno N., et al. Assessment of hepatic artery invasion by bile duct cancer using intraductal ultrasonography. Endoscopy 27 (1995) 579
38. Tamada K., Ido K., Ueno N., et al. Assessment of portal vein invasion by bile duct cancer using intraductal ultrasonography. Endoscopy 27 (1995) 573
39. Tamada K., Ido K., Ueno N., et al. Preoperative staging of extrahepatic bile duct cancer with intraductal ultrasonography. Am J Gastroenterol 90 (1995) 239
40. Levy M.J., Vazquez-Sequeiros E., and Wiersema M.J. Evaluation of the pancreaticobiliary ductal systems by intraductal US. Gastrointest Endosc 55 (2002) 397
41. Domagk D., Wessling J., Reimer P., et al. Endoscopic retrograde cholangiopancreatography, intraductal ultrasonography, and magnetic resonance cholangiopancreatography in bile duct strictures: a prospective comparison of imaging diagnostics with histopathological correlation. Am J Gastroenterol 99 (2004) 1684
42. Stavropoulos S., Larghi A., Verna E., et al. Intraductal ultrasound for the evaluation of patients with biliary strictures and no abdominal mass on computed tomography. Endoscopy 37 (2005) 715
43. Tamada K., Tomiyama T., Wada S., et al. Endoscopic transpapillary bile duct biopsy with the combination of intraductal ultrasonography in the diagnosis of biliary strictures. Gut 50 (2002) 326
44. Vazquez-Sequeiros E., Baron T.H., Clain J.E., et al. Evaluation of indeterminate bile duct strictures by intraductal US. Gastrointest Endosc 56 (2002) 372
45. Fukuda Y., Tsuyuguchi T., Sakai Y., et al. Diagnostic utility of peroral cholangioscopy for various bile-duct lesions. Gastrointest Endosc 62 (2005) 374
46. Shah R.J., Langer D.A., Antillon M.R., et al. Cholangioscopy and cholangioscopic forceps biopsy in patients with indeterminate pancreaticobiliary pathology. Clin Gastroenterol Hepatol 4 (2006) 219
47. Tischendorf J.J., Kruger M., Trautwein C., et al. Cholangioscopic characterization of dominant bile duct stenoses in patients with primary sclerosing cholangitis. Endoscopy 38 (2006) 665
48. Chen Y.K., and Pleskow D.K. SpyGlass single-operator peroral cholangiopancreatoscopy system for the diagnosis and therapy of bile-duct disorders: a clinical feasibility study (with video). Gastrointest Endosc 65 (2007) 832
49. Hoffman A., Kiesslich R., Bittinger F., et al. Methylene blue-aided cholangioscopy in patients with biliary strictures: feasibility and outcome analysis. Endoscopy 40 (2008) 563
50. Jarnagin W.R., Fong Y., DeMatteo R.P., et al. Staging, resectability, and outcome in 225 patients with hilar cholangiocarcinoma. Ann Surg 234 (2001) 507
51. Hatfield A.R., Tobias R., Terblanche J., et al. Preoperative external biliary drainage in obstructive jaundice. A prospective controlled clinical trial. Lancet 2 (1982) 896
52. McPherson G.A., Benjamin I.S., Hodgson H.J., et al. Pre-operative percutaneous transhepatic biliary drainage: the results of a controlled trial. Br J Surg 71 (1984) 371
53. Pitt H.A., Gomes A.S., Lois J.F., et al. Does preoperative percutaneous biliary drainage reduce operative risk or increase hospital cost?. Ann Surg 201 (1985) 545
54. Hochwald S.N., Burke E.C., Jarnagin W.R., et al. Association of preoperative biliary stenting with increased postoperative infectious complications in proximal cholangiocarcinoma. Arch Surg 134 (1999) 261
55. Jagannath P., Dhir V., Shrikhande S., et al. Effect of preoperative biliary stenting on immediate outcome after pancreaticoduodenectomy. Br J Surg 92 (2005) 356
56. Pisters P.W., Hudec W.A., Hess K.R., et al. Effect of preoperative biliary decompression on pancreaticoduodenectomy-associated morbidity in 300 consecutive patients. Ann Surg 234 (2001) 47
57. Sohn T.A., Yeo C.J., Cameron J.L., et al. Do preoperative biliary stents increase postpancreaticoduodenectomy complications?. J Gastrointest Surg 4 (2000) 258
58. Cherqui D., Benoist S., Malassagne B., et al. Major liver resection for carcinoma in jaundiced patients without preoperative biliary drainage. Arch Surg 135 (2000) 302
59. Hemming A.W., Reed A.I., Fujita S., et al. Surgical management of hilar cholangiocarcinoma. Ann Surg 241 (2005) 693
60. Kawasaki S., Imamura H., Kobayashi A., et al. Results of surgical resection for patients with hilar bile duct cancer: application of extended hepatectomy after biliary drainage and hemihepatic portal vein embolization. Ann Surg 238 (2003) 84
61. Sano T., Shimada K., Sakamoto Y., et al. One hundred two consecutive hepatobiliary resections for perihilar cholangiocarcinoma with zero mortality. Ann Surg 244 (2006) 240
62. Arakura N., Takayama M., Ozaki Y., et al. Efficacy of preoperative endoscopic nasobiliary drainage for hilar cholangiocarcinoma. J Hepatobiliary Pancreat Surg 16 (2009) 473-477
63. Martin II R.C., Vitale G.C., Reed D.N., et al. Cost comparison of endoscopic stenting vs surgical treatment for unresectable cholangiocarcinoma. Surg Endosc 16 (2002) 667
64. Smith A.C., Dowsett J.F., Russell R.C., et al. Randomised trial of endoscopic stenting versus surgical bypass in malignant low bile duct obstruction. Lancet 344 (1994) 1655
65. Sunpaweravong S., Ovartlarnporn B., Khow-ean U., et al. Endoscopic stenting versus surgical bypass in advanced malignant distal bile duct obstruction: cost-effectiveness analysis. Asian J Surg 28 (2005) 262
66. Levy M.J., Baron T.H., Gostout C.J., et al. Palliation of malignant extrahepatic biliary obstruction with plastic versus expandable metal stents: an evidence-based approach. Clin Gastroenterol Hepatol 2 (2004) 273
67. Baer H.U., Rhyner M., Stain S.C., et al. The effect of communication between the right and left liver on the outcome of surgical drainage for jaundice due to malignant obstruction at the hilus of the liver. HPB Surg 8 (1994) 27
68. De Palma G.D., Pezzullo A., Rega M., et al. Unilateral placement of metallic stents for malignant hilar obstruction: a prospective study. Gastrointest Endosc 58 (2003) 50
69. Freeman M.L., and Overby C. Selective MRCP and CT-targeted drainage of malignant hilar biliary obstruction with self-expanding metallic stents. Gastrointest Endosc 58 (2003) 41
70. Hintze R.E., Abou-Rebyeh H., Adler A., et al. Magnetic resonance cholangiopancreatography-guided unilateral endoscopic stent placement for Klatskin tumors. Gastrointest Endosc 53 (2001) 40
71. Chang W.H., Kortan P., and Haber G.B. Outcome in patients with bifurcation tumors who undergo unilateral versus bilateral hepatic duct drainage. Gastrointest Endosc 47 (1998) 354
72. Deviere J., Baize M., de Toeuf J., et al. Long-term follow-up of patients with hilar malignant stricture treated by endoscopic internal biliary drainage. Gastrointest Endosc 34 (1988) 95
73. De Palma G.D., Galloro G., Siciliano S., et al. Unilateral versus bilateral endoscopic hepatic duct drainage in patients with malignant hilar biliary obstruction: results of a prospective, randomized, and controlled study. Gastrointest Endosc 53 (2001) 547
74. Pedersen F.M. Endoscopic management of malignant biliary obstruction. Is stent size of 10 French gauge better than 7 French gauge?. Scand J Gastroenterol 28 (1993) 185
75. Davids P.H., Groen A.K., Rauws E.A., et al. Randomised trial of self-expanding metal stents versus polyethylene stents for distal malignant biliary obstruction. Lancet 340 (1992) 1488
76. Kaassis M., Boyer J., Dumas R., et al. Plastic or metal stents for malignant stricture of the common bile duct? Results of a randomized prospective study. Gastrointest Endosc 57 (2003) 178
77. Knyrim K., Wagner H.J., Pausch J., et al. A prospective, randomized, controlled trial of metal stents for malignant obstruction of the common bile duct. Endoscopy 25 (1993) 207
78. Prat F., Chapat O., Ducot B., et al. A randomized trial of endoscopic drainage methods for inoperable malignant strictures of the common bile duct. Gastrointest Endosc 47 (1998) 1
79. Soderlund C., and Linder S. Covered metal versus plastic stents for malignant common bile duct stenosis: a prospective, randomized, controlled trial. Gastrointest Endosc 63 (2006) 986
80. Wagner H.J., Knyrim K., Vakil N., et al. Plastic endoprostheses versus metal stents in the palliative treatment of malignant hilar biliary obstruction. A prospective and randomized trial. Endoscopy 25 (1993) 213
81. Perdue D.G., Freeman M.L., DiSario J.A., et al. Plastic versus self-expanding metallic stents for malignant hilar biliary obstruction: a prospective multicenter observational cohort study. J Clin Gastroenterol 42 (2008) 1040
82. Yeoh K.G., Zimmerman M.J., Cunningham J.T., et al. Comparative costs of metal versus plastic biliary stent strategies for malignant obstructive jaundice by decision analysis. Gastrointest Endosc 49 (1999) 466
83. Isayama H., Komatsu Y., Tsujino T., et al. Polyurethane-covered metal stent for management of distal malignant biliary obstruction. Gastrointest Endosc 55 (2002) 366
84. Isayama H., Komatsu Y., Tsujino T., et al. A prospective randomised study of "covered" versus "uncovered" diamond stents for the management of distal malignant biliary obstruction. Gut 53 (2004) 729
85. Park do H., Kim M.H., Choi J.S., et al. Covered versus uncovered wallstent for malignant extrahepatic biliary obstruction: a cohort comparative analysis. Clin Gastroenterol Hepatol 4 (2006) 790
86. Yoon W.J., Lee J.K., Lee K.H., et al. A comparison of covered and uncovered Wallstents for the management of distal malignant biliary obstruction. Gastrointest Endosc 63 (2006) 996
87. Fumex F., Coumaros D., Napoleon B., et al. Similar performance but higher cholecystitis rate with covered biliary stents: results from a prospective multicenter evaluation. Endoscopy 38 (2006) 787
88. Berr F., Wiedmann M., Tannapfel A., et al. Photodynamic therapy for advanced bile duct cancer: evidence for improved palliation and extended survival. Hepatology 31 (2000) 291
89. Dumoulin F.L., Gerhardt T., Fuchs S., et al. Phase II study of photodynamic therapy and metal stent as palliative treatment for nonresectable hilar cholangiocarcinoma. Gastrointest Endosc 57 (2003) 860
90. Harewood G.C., Baron T.H., Rumalla A., et al. Pilot study to assess patient outcomes following endoscopic application of photodynamic therapy for advanced cholangiocarcinoma. J Gastroenterol Hepatol 20 (2005) 415
91. McCaughan Jr. J.S., Mertens B.F., Cho C., et al. Photodynamic therapy to treat tumors of the extrahepatic biliary ducts. A case report. Arch Surg 126 (1991) 111
92. Ortner M.A., Liebetruth J., Schreiber S., et al. Photodynamic therapy of nonresectable cholangiocarcinoma. Gastroenterology 114 (1998) 536
93. Rumalla A., Baron T.H., Wang K.K., et al. Endoscopic application of photodynamic therapy for cholangiocarcinoma. Gastrointest Endosc 53 (2001) 500
94. Ortner M.E., Caca K., Berr F., et al. Successful photodynamic therapy for nonresectable cholangiocarcinoma: a randomized prospective study. Gastroenterology 125 (2003) 1355
95. Zoepf T., Jakobs R., Arnold J.C., et al. Palliation of nonresectable bile duct cancer: improved survival after photodynamic therapy. Am J Gastroenterol 100 (2005) 2426
96. Nanashima A., Yamaguchi H., Shibasaki S., et al. Adjuvant photodynamic therapy for bile duct carcinoma after surgery: a preliminary study. J Gastroenterol 39 (2004) 1095
97. Berr F., Tannapfel A., Lamesch P., et al. Neoadjuvant photodynamic therapy before curative resection of proximal bile duct carcinoma. J Hepatol 32 (2000) 352
98. Wiedmann M., Caca K., Berr F., et al. Neoadjuvant photodynamic therapy as a new approach to treating hilar cholangiocarcinoma: a phase II pilot study. Cancer 97 (2003) 2783
99. Wang L.W., Li L.B., Li Z.S., et al. Self-expandable metal stents and trans-stent light delivery: are metal stents and photodynamic therapy compatible?. Lasers Surg Med 40 (2008) 651
100. Bowling T.E., Galbraith S.M., Hatfield A.R., et al. A retrospective comparison of endoscopic stenting alone with stenting and radiotherapy in non-resectable cholangiocarcinoma. Gut 39 (1996) 852
101. Foo M.L., Gunderson L.L., Bender C.E., et al. External radiation therapy and transcatheter iridium in the treatment of extrahepatic bile duct carcinoma. Int J Radiat Oncol Biol Phys 39 (1997) 929
102. Gerhards M.F., van Gulik T.M., Gonzalez Gonzalez D., et al. Results of postoperative radiotherapy for resectable hilar cholangiocarcinoma. World J Surg 27 (2003) 173
103. Valek V., Kysela P., Kala Z., et al. Brachytherapy and percutaneous stenting in the treatment of cholangiocarcinoma: a prospective randomised study. Eur J Radiol 62 (2007) 175
104. Bruha R., Petrtyl J., Kubecova M., et al. Intraluminal brachytherapy and selfexpandable stents in nonresectable biliary malignancies-the question of long-term palliation. Hepatogastroenterology 48 (2001) 631
105. Simmons D.T., Baron T.H., Petersen B.T., et al. A novel endoscopic approach to brachytherapy in the management of Hilar cholangiocarcinoma. Am J Gastroenterol 101 (2006) 1792
106. Prat F., Lafon C., De Lima D.M., et al. Endoscopic treatment of cholangiocarcinoma and carcinoma of the duodenal papilla by intraductal high-intensity US: results of a pilot study. Gastrointest Endosc 56 (2002) 909
107. Prat F., Lafon C., Theilliere J.Y., et al. Destruction of a bile duct carcinoma by intraductal high intensity ultrasound during ERCP. Gastrointest Endosc 53 (2001) 797